| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Biometrics | | | | | | | 15.0 | 12.0 |
| Other | | | | | | | 1.1 | 3.5 |
| Total revenues [+] | 16.0 | 16.0 | 16.9 | 16.9 | 11.3 | 12.2 | 16.1 | 15.5 |
| Services | | 1.5 | | 2.2 | | | | |
| Revenue growth [+] | -5.0% | -5.0% | 49.0% | | -7.3% | -24.3% | 4.3% | -28.3% |
| Biometrics | | | | | | | 25.8% | -27.8% |
| Goods or services transferred over time | | | | | | | 64.3% | |
| Cost of goods sold | 1.3 | 1.3 | 1.2 | 1.2 | 0.8 | 1.3 | 1.2 | 0.9 |
| Gross profit | 14.7 | 14.7 | 15.6 | 15.6 | 10.5 | 10.9 | 14.9 | 14.6 |
| Gross margin | 92.1% | 92.1% | 92.8% | 92.8% | 92.8% | 89.7% | 92.3% | 94.3% |
| Selling, general and administrative [+] | 13.4 | 13.4 | 12.5 | 12.5 | 10.8 | 7.2 | 7.5 | 7.3 |
| Sales and marketing | 7.0 | 7.0 | 6.3 | 6.3 | 5.4 | 3.6 | 4.2 | 3.9 |
| General and administrative | 6.4 | 6.4 | 6.2 | 6.2 | 5.4 | 3.6 | 3.3 | 3.4 |
| Research and development | 9.2 | 9.2 | 9.3 | 9.3 | 9.1 | 7.9 | 7.1 | 7.8 |
| Other operating expenses | | | | | | | -0.1 | -1.6 |
| EBITDA [+] | -7.1 | | -5.4 | | -8.9 | -3.7 | 0.8 | 1.6 |
| EBITDA growth | 31.8% | 29.4% | -39.0% | | 137.2% | -553.5% | -49.3% | -75.1% |
| EBITDA margin | -44.5% | -49.3% | -32.1% | -36.2% | -78.4% | -30.6% | 5.1% | 10.5% |
| Depreciation | 0.3 | | 0.5 | | 0.6 | 0.4 | 0.4 | 0.5 |
| EBITA | -7.5 | -7.9 | -5.9 | -6.1 | -9.4 | -4.2 | 0.4 | 1.1 |
| EBITA margin | -46.7% | -49.3% | -35.1% | -36.2% | -83.3% | -34.2% | 2.4% | 7.2% |
| Amortization of intangibles | 0.4 | | 0.2 | | | | | |
| EBIT [+] | -7.9 | -7.9 | -6.1 | -6.1 | -9.4 | -4.2 | 0.4 | 1.1 |
| EBIT growth | 29.4% | 29.4% | -35.3% | | 125.6% | -1196.6% | -65.6% | -81.3% |
| EBIT margin | -49.3% | -49.3% | -36.2% | -36.2% | -83.3% | -34.2% | 2.4% | 7.2% |
| Non-recurring items [+] | -5.7 | -5.7 | | | | | | |
| Loss (gain) on sale of assets | -5.7 | -5.7 | | | | | | |
| Interest income | 0.5 | | 0.0 | | 0.2 | 1.0 | 0.8 | 0.4 |
| Interest income | 0.5 | | 0.0 | | 0.2 | 1.0 | 0.8 | 0.4 |
| Other income (expense), net [+] | | 0.5 | | 0.0 | | | | 0.0 |
| Other | | | | | | | | 0.0 |
| Pre-tax income | -1.7 | -1.7 | -6.1 | -6.1 | -9.2 | -3.1 | 1.2 | 1.5 |
| Income taxes | 0.0 | 0.0 | -0.3 | -0.3 | -1.6 | 5.2 | 0.0 | 0.5 |
| Tax rate | | | 4.4% | 4.4% | 17.7% | | | 35.2% |
| Net income | -1.7 | -1.7 | -5.8 | -5.8 | -7.6 | -8.3 | 1.2 | 1.0 |
| Net margin | -10.8% | -10.8% | -34.6% | -34.6% | -67.3% | -68.3% | 7.6% | 6.5% |
| |
| Basic EPS [+] | ($0.08) | ($0.08) | ($0.27) | ($0.27) | ($0.35) | ($0.39) | $0.06 | $45.76 |
| Growth | -70.5% | -70.5% | -23.7% | | -8.5% | -777.1% | -99.9% | 25358.4% |
| Diluted EPS [+] | ($0.08) | ($0.08) | ($0.27) | ($0.27) | ($0.35) | ($0.39) | $0.06 | $0.05 |
| Growth | -70.5% | -70.5% | -23.7% | | -8.5% | -779.0% | 24.4% | -74.4% |
| |
| |
| Shares outstanding (basic) [+] | 21.6 | 21.6 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 0.0 |
| Growth | 0.4% | 0.4% | 0.2% | | -0.2% | -0.1% | 98377.9% | -99.9% |
| Shares outstanding (diluted) [+] | 21.6 | 21.6 | 21.5 | 21.5 | 21.5 | 21.5 | 21.6 | 21.8 |
| Growth | 0.4% | 0.4% | 0.2% | | -0.2% | -0.4% | -1.0% | -4.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |